News for Caregen Co., Ltd. (214370.KQ)

Published at

Oct 8, 2024 7:00 PM

by globenewswire.com

mixed

mixed

VEGFR-2 Antagonists Clinical Trial Pipeline Insights Featuring 25+ Companies | DelveInsight

VEGFR2 (vascular endothelial growth factor receptor 2) antagonist is an antineoplastic agent that blocks the binding of natural VEGF ligands, which are...

OTLK 321550.KQ UBX OPT.AX OPT LLY.DE LLY.BA LLY LILY34.SA KOD EYPT CKDXF AGTC 0YC0.L 0Q1G.L OCUL INCY I1NC34.SA CLSD ADVM 214370.KQ 0J9P.L 0HA3.L

Read more →
Published at

Jan 31, 2024 7:00 PM

by globenewswire.com

mixed

mixed

Wet-Age Related Macular Degeneration Market to Observe Stupendous Growth by 2032, Predicts DelveInsight | Key Players - AbbVie, Opthea, AffaMed Therapeutics, EyeBiotech, Novartis, Hoffmann-La Roche, K

The increasing number of diagnosed cases of wet AMD, the current therapies, and the launch of emerging therapies will drive the wet AMD market growth in...

OPT.AX OPT EYPT CKDXF UBX OTLK OCUL KOD.MX KOD CLSD ADVM 214370.KQ 0YC0.L 0HA3.L

Read more →